ArticleCureus2024

Evaluating the Usage of Janus Kinase Inhibitors in Rheumatology and Its Impact on Cardiovascular Risk.

Knkush Hakobyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.